SCHEMBL9047602

SCHEMBL9047602

O=C[C@H]1NCCC1C(=O)[C@H]1NCC(=S)C1C(=O)CCCCC1=Cc2ccccc2C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9050844 0.97 ACHE (0.30) ACHE
SCHEMBL9049370 0.94 ACHE (0.31) ACHE
SCHEMBL9047815 0.90 PREP (0.34) ACHE
SCHEMBL9050872 0.87
SCHEMBL9050743 0.84
SCHEMBL9045918 0.81
SCHEMBL9050827 0.81 PREP (0.30)
SCHEMBL9049083 0.79 PREP (0.41) ACHE
SCHEMBL7301155 0.78 PREP (0.35) ACHE
SCHEMBL9047864 0.76 PREP (0.41) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed